TB Notes Newsletter
This is an archived document. The links
and content are no longer being updated.
No. 4, 2006
New CDC Publications
Andre MD, Ijaz K, Tillinghast JD, Krebs VE, Diem LA,
Metchock B, Crisp T, and McElroy PD. Transmission
network analysis to complement routine tuberculosis
contact investigations. Am J Public Health Nov. 2006; 96 (11):1-8.
Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle
M, Mosher AW, Choudhri S, Daley CL, Munsiff SS, Zhao Z,
Vernon A, Chaisson RE, and the Tuberculosis Trials
Consortium. Moxifloxacin versus ethambutol in the first
2 months of treatment for pulmonary tuberculosis.
Am J Respir Crit Care Med 2006; 174:331-338.
Butler WR, Floyd MM, Brown JM, Toney SR, Daneshvar
MI, Cooksey RC, Carr J, Steigerwalt AG, Charles N. Novel
mycolic acid–containing bacteria in the family
Segniliparaceae fam. nov., including the genus
Segniliparus gen. nov., with descriptions of
Segniliparus rotundus sp. nov. and Segniliparus rugosus
sp. nov. International Journal of Systematic and Evolutionary
Microbiology 2005; 55: 1615-1624.
CDC. Prevention and control of tuberculosis in
correctional and detention facilities: recommendations
from CDC. MMWR July 2006; 55 (RR-9).
Holtz TH, Lancaster J, Laserson KF, Wells CD, Thorpe
L, Weyer K. Risk factors associated with default from
multidrug-resistant tuberculosis treatment, South
Africa, 1999–2001. Int J Tuberc Lung Dis June 2006; 10(6):649-655.
Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR,
and the Tuberculosis Trials Consortium. Lack of weight
gain and relapse risk in a large tuberculosis treatment
trial. Am J Respir Crit Care Med 2006; 174:344-348.
Lofy KH, McElroy PD, Lake L, Cowan LS, Diem LA,
Goldberg SV, Cangelosi GA, Tribble SP, Cave MD, Narita
M. Outbreak of tuberculosis in a homeless population
involving multiple sites of transmission.
Int J Tuberc Lung Dis June 2006; 10(6):683-689.
Macaraig M, Agerton T, Driver CR, Munsiff SS,
Abdelwahab J, Park J, Kreiswirth B, Driscoll J, and Zhao
B. Strain-specific differences in two large
Mycobacterium tuberculosis genotype clusters in
isolates collected from homeless patients in New York
City from 2001 to 2004. Journal of Clinical Microbiology 2006 Aug; 44(8):
2890-6.
Manangan LP, Moore M, Macaraig M, MacNeil J, Shevick
G, Northrup J, Pratt R, Adams LV, Boutotte J,
Sharnprapai S, Qualls N. Health department costs of
managing persons with suspected and noncounted
tuberculosis in New York City, three Texas counties, and
Massachusetts. J Public Health Management and Practice 2006; 12(3):
248-253.
Moonan PK, Oppong J, Sahbazian B, Singh KP, Sandhu R,
Drewyer G, Lafon T, Marruffo M, Quitugua TN, Wallace C,
and Weis SE. What is the outcome of targeted
tuberculosis screening based on universal genotyping and
location? American Journal of Respiratory and
Critical Care Medicine 2006 Sep 1; 174(5): 599-604.
Mugisha B, Bock N, Mermin J, Odeke RM, Miller B,
Adatu-Engwau F, Granich R, Bunnell R. Tuberculosis case
finding and preventive therapy in an HIV voluntary
counseling and testing center in Uganda. Int J Tuberc Lung Dis July 2006;10(7):761-767.
Munsiff SS, Ahuja SD, King L, Udeagu C-C, Dorsinville
M, Frieden TR, Fujiwara PI. Ensuring accountability: the
contribution of the cohort review method to tuberculosis
control in New York City. Int J Tuberc Lung Dis 2006; 10(10): 1133-1139.
Munsiff SS, Ahuja SD, Li J, Driver CR. Public-private
collaboration for multidrug-resistant tuberculosis
control in New York City. Int J Tuberc Lung Dis June 2006; 10(6): 639-648.
Munsiff SS, Li J, Cook SV, Piatek A, Laraque F,
Ebrahimzadeh A, and Fujiwara PI. Trends in
drug-resistant Mycobacterium tuberculosis in New
York City, 1991-2003. Clinical Infectious Diseases
2006 Jun 15; 42(12): 1702-10. Also Epub 2006 May 12.
Nathanson E, Lambregts-van Weezenbeek C, Rich ML,
Gupta R, Bayona J, Blöndal K, et al. Multidrug-resistant
tuberculosis management in resource-limited settings.
Emerg Infect Dis Sept 2006; 12(9):1389-1397.
Also available from
http://www.cdc.gov/ncidod/EID/vol12no09/05-1618.htm
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb
JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader
DB, Bernardo J, Venkataramanan R, and Sterling TR. An
Official ATS Statement: Hepatotoxicity of
Antituberculosis Therapy. American Journal of
Respiratory and Critical Care Medicine 2006 Oct 15;
174 (8):935-52.
Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N,
Mangura B, Weiner M, Vernon A for the Tuberculosis
Trials Consortium. Mortality in a large tuberculosis
treatment trial: modifiable and non-modifiable risk
factors. Int J Tuberc Lung Dis May 2006; 10(5):542-549.
Yagui M, Perales MT, Asencios L, Vergara L, Suarez C,
Yale G, Salazar C, Saavedra M, Shin S, Ferrousier O,
Cegielski P. Timely diagnosis of MDR-TB under program
conditions: is rapid drug susceptibility testing
sufficient? Int J Tuberc Lung Dis August 2006; 10(8):838-843. |
